CA2855971C - Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma - Google Patents

Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma Download PDF

Info

Publication number
CA2855971C
CA2855971C CA2855971A CA2855971A CA2855971C CA 2855971 C CA2855971 C CA 2855971C CA 2855971 A CA2855971 A CA 2855971A CA 2855971 A CA2855971 A CA 2855971A CA 2855971 C CA2855971 C CA 2855971C
Authority
CA
Canada
Prior art keywords
head
cell carcinoma
squamous cell
neck squamous
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2855971A
Other languages
English (en)
French (fr)
Other versions
CA2855971A1 (en
Inventor
Elizabeth Franzmann
Lutecia PEREIRA
Isildinha M. Reis
Robert C. Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of CA2855971A1 publication Critical patent/CA2855971A1/en
Application granted granted Critical
Publication of CA2855971C publication Critical patent/CA2855971C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585—CD44
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
CA2855971A 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma Expired - Fee Related CA2855971C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161559974P 2011-11-15 2011-11-15
US61/559,974 2011-11-15
US201261654595P 2012-06-01 2012-06-01
US61/654,595 2012-06-01
PCT/US2012/065282 WO2013074793A1 (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Publications (2)

Publication Number Publication Date
CA2855971A1 CA2855971A1 (en) 2013-05-23
CA2855971C true CA2855971C (en) 2022-01-04

Family

ID=48430146

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2855971A Expired - Fee Related CA2855971C (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Country Status (13)

Country Link
US (3) US20140329230A1 (https=)
EP (1) EP2780714B1 (https=)
JP (1) JP6174035B2 (https=)
CN (1) CN104067126B (https=)
AU (3) AU2012340441A1 (https=)
BR (1) BR112014011563B1 (https=)
CA (1) CA2855971C (https=)
CO (1) CO6980621A2 (https=)
ES (1) ES2640532T3 (https=)
IL (1) IL232556A (https=)
MX (1) MX352642B (https=)
PE (1) PE20141565A1 (https=)
WO (1) WO2013074793A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2015017692A1 (en) * 2013-07-31 2015-02-05 University Of Miami Compositions and methods for identifying a risk of cancer in a subject
WO2015026827A2 (en) * 2013-08-19 2015-02-26 University Of Notre Dame Method and composition for detection of oncogenic hpv
WO2015179712A1 (en) 2014-05-22 2015-11-26 University Of Notre Dame Du Lac Integrated membrane sensor for rapid molecular detection
WO2016209703A1 (en) * 2015-06-22 2016-12-29 The Johns Hopkins University Head and neck squamous cell carcinoma assays
JP6655243B2 (ja) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 口腔前癌病変の検出方法
CN107092854B (zh) * 2016-02-18 2020-05-22 财团法人金属工业研究发展中心 检测细胞受人类乳头瘤病毒(hpv)感染的装置及其检测方法
GB201808839D0 (en) 2018-05-30 2018-07-11 Cancer Research Tech Ltd Method of predicting survival rates for cancer patients
WO2020018954A1 (en) * 2018-07-20 2020-01-23 Predentome, Inc. Methods and systems for oral microbiome analysis
US20220137041A1 (en) * 2019-02-26 2022-05-05 University Of Miami Device for methods of detecting cancer
US20240188897A1 (en) * 2021-04-23 2024-06-13 The University Of Chicago Machine learning based histopathological recurrence prediction models for hpv+ head / neck squamous cell carcinoma
CN120359416A (zh) * 2022-10-17 2025-07-22 伟吉朗特生物科学公司 用于口腔癌风险的方法和组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403551A (en) 1993-09-16 1995-04-04 Roche Diagnostic Systems, Inc. Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US7189397B2 (en) 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20040029114A1 (en) 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
ATE289685T1 (de) * 2003-08-25 2005-03-15 Mtm Lab Ag Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
JP4563186B2 (ja) 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
WO2005095987A2 (en) * 2004-03-26 2005-10-13 University Of Miami Salivary soluble cd44: a molecular marker for head and neck cancer
WO2007129999A2 (en) 2004-07-14 2007-11-15 Biospectrum, Inc. Antiproliferative peptides and antibodies for their detection
US20090197285A1 (en) 2005-11-10 2009-08-06 University Of Kentucky Lung Cancer Diagnostic Assay
WO2007133725A1 (en) 2006-05-12 2007-11-22 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
CN101230390A (zh) * 2007-12-07 2008-07-30 湖北大学 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
EP2364371A4 (en) * 2008-11-24 2012-05-02 Univ Loma Linda BIOMARKER FOR DETECTING HEADS AND HALSTUMORS
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Also Published As

Publication number Publication date
BR112014011563A2 (pt) 2017-05-09
AU2020277155A1 (en) 2020-12-24
US20160305942A1 (en) 2016-10-20
IL232556A (en) 2017-12-31
EP2780714A1 (en) 2014-09-24
AU2018203361A1 (en) 2018-05-31
MX2014005887A (es) 2014-09-08
JP2014533372A (ja) 2014-12-11
EP2780714A4 (en) 2015-07-15
WO2013074793A1 (en) 2013-05-23
CN104067126A (zh) 2014-09-24
US20150219656A1 (en) 2015-08-06
PE20141565A1 (es) 2014-10-25
CN104067126B (zh) 2017-04-12
US20140329230A1 (en) 2014-11-06
AU2012340441A1 (en) 2014-05-29
IL232556A0 (en) 2014-06-30
ES2640532T3 (es) 2017-11-03
US10180431B2 (en) 2019-01-15
EP2780714B1 (en) 2017-08-16
US10180430B2 (en) 2019-01-15
BR112014011563B1 (pt) 2022-05-24
MX352642B (es) 2017-12-01
JP6174035B2 (ja) 2017-08-02
AU2018203361B2 (en) 2020-08-27
CA2855971A1 (en) 2013-05-23
CO6980621A2 (es) 2014-06-27

Similar Documents

Publication Publication Date Title
CA2855971C (en) Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
EP2583100A4 (en) ROTORS FOR IMMUNOASSAYS
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
WO2012097081A3 (en) Protein detection method
WO2014143977A3 (en) Biomarkers and methods for predicting preeclampsia
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
NZ628463A (en) Ratio based biomarkers and methods for use thereof
GB201209668D0 (en) Methods of monitoring conditions by sequence analysis
EP4575505A3 (en) Biomarkers and methods for predicting preterm birth
MX2014006118A (es) Deteccion de analitos.
WO2012139047A3 (en) Identifying and enumerating early granulated cells (egcs)
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
HK1215259A1 (zh) 檢測抗苗勒管激素的同種型的抗體組合物及免疫測定方法
JP2014533372A5 (https=)
EP4617668A3 (en) Methods for quantitation of insulin and c-peptide
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
EA201370070A1 (ru) СПОСОБ ДЕТЕКЦИИ, ДИФФЕРЕНЦИАЦИИ И КВАНТИФИКАЦИИ ПОПУЛЯЦИЙ Т-КЛЕТОК С ИСПОЛЬЗОВАНИЕМ КОЛИЧЕСТВЕННОЙ ПЦР С ОБРАТНОЙ ТРАНСКРИПЦИЕЙ В РЕАЛЬНОМ ВРЕМЕНИ (ОТ-колПЦР РВ)
EP4513499A3 (en) Method and device for analyzing target analyte in sample
WO2012032345A3 (en) Biomarker signatures and uses thereof
SG195180A1 (en) Method for detecting disease biomarkers
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
EP4450648A3 (en) Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
GB2494580A (en) Method for diagnosing lung cancer
WO2013076579A3 (en) Method for assessing risk of bone fracture
WO2012153964A3 (ko) 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170830

MKLA Lapsed

Effective date: 20221115